United States · Platforms & data · The Motley Fool

Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript

Published by The Motley Fool · United States 1 h ago

Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

MSA Safety beats top-line estimates; reaffirms FY26 outlook

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

GraniteShares 3x Short Palantir Daily ETC 3SPA ETF Analysis